Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferonα2a and tamoxifen in metastatic melanoma

M. R. Sertoli, P. Queirolo, E. Bajetta, M. DelVecchio, G. Comella, L. Barduagni, M. G. Bernengo, S. Vecchio, D. Criscuolo, R. Bufalino, A. Morabito, N. Cascinelli

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferonα2a and tamoxifen in metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences